These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3904427)

  • 1. Aluminum-induced anemia.
    Kaiser L; Schwartz KA
    Am J Kidney Dis; 1985 Nov; 6(5):348-52. PubMed ID: 3904427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aluminum in tissues.
    Van de Vyver FL; De Broe ME
    Clin Nephrol; 1985; 24 Suppl 1():S37-57. PubMed ID: 3915959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative contributions of body iron status and uremia severity to anemia in patients with advanced chronic renal failure.
    Ifudu O; Dawood M; Friedman EA
    Nephron; 1997; 77(3):315-8. PubMed ID: 9375826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aluminum induced anemia: pathogenesis and treatment in patients on chronic hemodialysis.
    Bia MJ; Cooper K; Schnall S; Duffy T; Hendler E; Malluche H; Solomon L
    Kidney Int; 1989 Nov; 36(5):852-8. PubMed ID: 2615192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aluminum and iron deposition in dialysis patients].
    Kurihara S; Marumo F
    Nihon Rinsho; 1992 Jan; 50 Suppl():905-10. PubMed ID: 1578787
    [No Abstract]   [Full Text] [Related]  

  • 6. Correction of microcytosis following elimination of an occult source of aluminum contamination of dialysate.
    Abreo K; Brown ST; Sella M
    Am J Kidney Dis; 1989 Jun; 13(6):465-8. PubMed ID: 2729267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of aluminum in the pathogenesis of anemia in an outpatient hemodialysis population.
    Yuan B; Klein MH; Contiguglia RS; Mishell JL; Seligman PA; Miller NL; Molitoris BA; Alfrey AC; Shapiro JI
    Ren Fail; 1989; 11(2-3):91-6. PubMed ID: 2623200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microcytic anemia in dialysis patients: reversible marker of aluminum toxicity.
    Swartz R; Dombrouski J; Burnatowska-Hledin M; Mayor G
    Am J Kidney Dis; 1987 Mar; 9(3):217-23. PubMed ID: 3826071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Water content of aluminum, dialysis dementia, and osteomalacia.
    Wills MR; Savory J
    Environ Health Perspect; 1985 Nov; 63():141-7. PubMed ID: 3908086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is aluminum toxicity responsible for uremic pruritus in chronic hemodialysis patients?
    Friga V; Linos A; Linos DA
    Nephron; 1997; 75(1):48-53. PubMed ID: 9031270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adynamic bone disease, anaemia, resistance to erythropoietin and iron-aluminium interaction.
    Drüeke TB
    Nephrol Dial Transplant; 1993; 8 Suppl 1():12-6. PubMed ID: 8389015
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathogenesis of anemia due to kidney disease].
    Blumberg A
    Nephron; 1989; 51 Suppl 1():15-9. PubMed ID: 2644577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum.
    Tsai JC; Lai YH; Tsai ZY; Chien LJ; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of aluminum in osteodystrophy and anemia in chronic renal failure].
    Cannata Andía JB
    An Med Interna; 1991 Jun; 8 Suppl 2():21. PubMed ID: 1878466
    [No Abstract]   [Full Text] [Related]  

  • 15. Aluminum-induced microcytosis in a child with moderate renal insufficiency.
    Shah NR; Oberkircher OR; Lobel JS
    Am J Pediatr Hematol Oncol; 1990; 12(1):77-9. PubMed ID: 2309983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of aluminum-induced hemodialysis anemia by a low-aluminum dialysate.
    O'Hare JA; Murnaghan DJ
    N Engl J Med; 1982 Mar; 306(11):654-6. PubMed ID: 7057824
    [No Abstract]   [Full Text] [Related]  

  • 17. Microcytic anemia secondary to intraperitoneal aluminum in normal and uremic rats.
    Kaiser L; Schwartz KA; Burnatowska-Hledin MA; Mayor GH
    Kidney Int; 1984 Sep; 26(3):269-74. PubMed ID: 6513272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminium-induced, reversible microcytic anemia in chronic renal failure: clinical and experimental studies.
    Touam M; Martinez F; Lacour B; Bourdon R; Zingraff J; Di Giulio S; Drüeke T
    Clin Nephrol; 1983 Jun; 19(6):295-8. PubMed ID: 6872366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure.
    McGonigle RJ; Wallin JD; Husserl F; Deftos LJ; Rice JC; O'Neill WJ; Fisher JW
    J Lab Clin Med; 1984 Dec; 104(6):1016-26. PubMed ID: 6501997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cost-effectiveness analysis of anemia screening before erythropoietin in patients with end-stage renal disease.
    Hutchinson FN; Jones WJ
    Am J Kidney Dis; 1997 May; 29(5):651-7. PubMed ID: 9159297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.